Theralase Technologies Inc. (TLT) — research page
CA · ca-cm-kg/TSXV/TLT · as of 2026-11-06
Identity and listing
The issuer is Theralase Technologies Inc., listed on the TSXV under ticker TLT, with ISIN CA88337V1004 and LEI 529900NI3Y8GLE2IBF28. Its security type is Corporate, its segment is not on the record, its sector is Life Sciences, and its jurisdiction is Canada (federal, CBCA). The record holds its status as listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Theralase Technologies Inc. | source · 2026-11-06 |
| exchange | TSXV | source · 2026-11-06 |
| ticker | TLT | source · 2026-11-06 |
| ISIN | CA88337V1004 | source · 2026-11-06 |
| LEI | 529900NI3Y8GLE2IBF28 | source · 2026-11-06 |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | Life Sciences | source · 2026-11-06 |
| jurisdiction | Canada (federal, CBCA) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 15 filings across 14 filing days in the window 2025-11-06 to 2026-11-06. By type, the filings are 1 corporate action, 6 exchange bulletins, 1 halt-resume and 7 newswire releases. The median gap between filing days is 21 days, and the latest filing was 10 days before the record date of 2026-11-06, which lies 2026-10-27 as a newswire release. The TSXV median is 9 filings, a median cadence gap of 19 days and a median latency of 17.0 days. The Life Sciences sector median is 7.0 filings, a median cadence gap of 17.5 days and a median latency of 14 days. The issuer's 15 filings are above the TSXV median and above the sector median.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 15 | 21 | 10 |
| exchange median: TSXV (1427 issuers) | 9 | 19 | 17 |
| sector median: Life Sciences (200 issuers) | 7 | 17.5 | 14 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-27 | newswire_release | Theralase Provides Bladder Cancer Clinical Study Update | |
| 2026-10-26 | newswire_release | Theralase Provides Bladder Cancer Clinical Study Update | |
| 2026-10-09 | newswire_release | Theralase(R) to Present at ThinkEquity Conference | |
| 2026-09-15 | newswire_release | Theralase(R) Commences GLP Toxicology Analysis of Rutherrin(R) | |
| 2026-09-04 | exchange_bulletin | TSXV bulletin: PP-B (Financings that are not done thru an Exchange Offering Prospectus) |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is AGT Partners LLP, whose location is not on the record. The record holds no auditor changes.
Events and halts
The record holds one lifecycle line, a listing on 2026-06-05. It holds no delisting, domicile change, name change or segment move. The halt flag reads listed, not halted.
Orderability
Under paragraph (o) of the definition, the signal is ACM-200 and the outcome is determinable. Under paragraph (q) of the definition, the signal is ACM-200 and the outcome is determinable. The rule version is acm-68000/ca/kyp-know-your-product-ni-31-103/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| Paragraph (o) of the definition | ACM-200 |
| Paragraph (q) of the definition | ACM-200 |
rule acm-68000/ca/kyp-know-your-product-ni-31-103/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The field has not been read.
Open research
The field has not been read.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 in the store, but no issuer years are sealed as served. The market's vintage is not sealed, so the earliest sealed date is not on the record. The live record began on 2026-09-10. The as-of door answers not_sealed.
Sources
9 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.tsx.com/json/company-directory/search/tsxv/^* (identity.exchange)
- 10.2
- https://cn.investing.com/equities/theralase-technologies-inc (identity.isin)
- 10.3
- https://api.gleif.org/api/v1/lei-records/529900NI3Y8GLE2IBF28 (identity.jurisdiction)
- 10.4
- https://www.tsx.com/en/resource/571 (identity.sector)
- 10.5
- https://mcp.ca-cm-kg.ai/events/TSXV/TLT (the disclosure lines)
- 10.6
- https://iiroc.mediaroom.com/index.php?s=2429&l=100 (the halt flag)
- 10.7
- https://theralase.com/wp-content/uploads/2024/05/Theralase-Management-Information-Circular-2025-AGM-meeting-Final.pdf (the auditor)
- 10.8
- https://mcp.ca-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://mcp.ca-cm-kg.ai/record/TSXV/TLT (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"CA88337V1004"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:6fa93c7bc54e32ee.